Recent Company News

• 11:40 PM ET Mar 31, 2026
  

  StreetAccount Summary - Trading higher/lower: China mid-morning

• 04:43 AM ET Apr 28, 2026
  

  Hangzhou Tigermed Consulting reports Q1 net income attributable CNY49.0M vs year-ago CNY165.5M (CNY 58.39, 0.00)

• 06:12 AM ET Apr 17, 2026
  

  Hangzhou Tigermed Consulting initiated buy at China Post Securities (timing uncertain) (CNY 57.60, 0.00)

• 08:56 AM ET Apr 07, 2026
  

  Northeast Securities initiates 002422.CH, 300347.CH, 301301.CH, and 603127.CH

• 07:24 PM ET Apr 06, 2026
  

  Hangzhou Tigermed Consulting upgraded to neutral from underweight at JPMorgan (HK$42.70, 0.00)

• 06:57 AM ET Mar 30, 2026
  

  Hangzhou Tigermed Consulting releases sustainability report (CNY 52.68, 0.00)

• 04:39 AM ET Mar 30, 2026
  

  Hangzhou Tigermed Consulting reports FY CAS net income attributable CNY887.9M vs guidance CNY0.83-1.23B and FactSet CNY1.11B [9 est, CNY941.2-1.48B] (CNY 52.68, 0.00)